Abstract
In patients with intermittent claudication, 24 weeks of treatment with ramipril improves pain-free and maximum treadmill walking times compared with placebo and is associated with a significant increase in the physical functioning component of the Short-Form 36 Health Survey (SF-36; Quality Metrics, Lincoln, RI).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
